ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 0946

Distinct Lipidomic Signatures in Synovium and Synovial Fluid of Patients with Rheumatoid Arthritis versus Psoriatic Arthritis

Beatriz Rocha1, Berta Cillero-Pastor2, Anna Illiano3, Valentina Calamia1, Gabriella Pinto4, Angela Amoresano4, Cristina Ruiz-Romero5, Juan D Cañete6, Ron MA Heeren2 and Francisco Blanco-García7, 1Unidad de Proteómica. Grupo de Investigación de Reumatología (GIR). Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC). C/ As Xubias de Arriba 84, 15006 A Coruña, España., A Coruña, Spain, 2The Maastricht Multimodal Molecular Imaging Institute (M4I), Division of Imaging Mass Spectrometry, Maastricht University, The Netherlands., Maastricht, Netherlands, 3CEINGE - Advanced Biotecnology, 80145 Napoli, Italy. Instituto Nazionale Biostrutture e Biosistemi (INBB), Rome, Italy., Naples, Italy, 4Department of Chemical Sciences, University of Naples “Federico II”, Napoli, Italy. Instituto Nazionale Biostrutture e Biosistemi (INBB), Rome, Italy, 5Unidad de Proteómica. Grupo de Investigación de Reumatología (GIR). Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC). C/ As Xubias de Arriba 84, 15006, A Coruña, España.Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN). Av. Monforte de Lemos, 3-5. Pabellón 11, 28029, Madrid, España., A Coruña, Spain, 6Rheumatology Department, Hospital Clinic, Barcelona, Spain, 7Unidad de Proteómica. Grupo de Investigación de Reumatología (GIR). Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC). C/ As Xubias de Arriba 84, 15006, A Coruña, España.Universidade da Coruña (UDC), Grupo de Investigación de Reumatología y Salud (GIR-S). Departamento de Fisioterapia, Medicina y Ciencias Biomédicas, Facultad de Fisioterapia, Campus de Oza, 15008, A Coruña, España., A Coruña, Spain

Meeting: ACR Convergence 2021

Keywords: Diagnostic criteria, lipidomics, Psoriatic arthritis, rheumatoid arthritis, synovial

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 7, 2021

Session Title: Abstracts: Spondyloarthritis Including PsA – Basic Science (0944–0947)

Session Type: Abstract Session

Session Time: 9:30AM-9:45AM

Background/Purpose: The differential diagnosis of Rheumatoid Arthritis (RA) and Psoriatic arthritis (PsA) is often difficult due to the similarity of symptoms and the unavailability of reliable clinical biomarkers. Lipid alterations have been suggested to contribute to the pathophysiological processes in the knee joint, and chronic inflammation induces significant changes in the synovium and synovial fluid (SF) lipidome. Therefore, we aimed to evaluate whether differences in the lipid profiles from synovial membrane (SM) and SF could support the differential diagnosis of these diseases.

Methods: SM samples of patients affected by RA (n=6), PsA (n=12) and control donors (n=10) were compared using Matrix-Assisted Laser Desorption Ionization Mass Spectrometry Imaging (MALDI-MSI) for spatially resolved lipid analysis. To this end, tissue sections were measured on a RapifleX MALDI-TOF/TOF instrument. Next, a targeted approach based on multiple reaction monitoring (MRM-MS) was performed to further validate the lipidomic alterations reported by MALDI-MSI between RA and PsA tissues. In this case, lipids extracted from SF (control donors (n=4), RA (n=21) and PsA (n=27)) were analyzed in a QTRAP 4000 mass spectrometer coupled with an ExpressHT™-Ultra HPLC system for the targeted analysis of 84 lipid species. Principal component analysis (PCA) and discriminant analysis (DA) were used for data interpretation.

Results: Lipid profiles of PsA and RA synovial membranes were unequivocally distinguished by MALDI-MSI followed by PCA-DA. Interestingly, several lipid species, including sphingomyelins, phosphatidylcholines (PC) and phosphatidylethanolamines (PE), presented the greatest separation power to classify RA and PsA tissue samples. On the other hand, the lipid profile of arthritic SM samples was also discriminated from control tissues. Specifically, several lysophosphatidylcholines showed the greatest discriminative capability for separating groups. The abundance of those lipid species with discriminatory potential were further compared using ANOVA. This analysis found 35 lipid species significantly different among the study groups, where most of them were significantly increased in RA and PsA compared to controls. Particularly, 11 lipids showed higher levels in PsA tissues compared with RA, including several PC and PE such as PE 34:1 and PE 36:1. The spatial distribution of these PE species was associated with areas of the sublining layer with increased vascularity and inflammatory cell infiltrates, according to MALDI-MSI images. On the other hand, RA and PsA patients were also correctly classified based on the SF levels of all quantified lipid species according to PCA and clustering analysis. Finally, we were able to validate the increased levels of PE 34:1 and PE 36:1 in the SF of PsA patients compared to RA (Figure 1).

Conclusion: Our study shows a distinct lipid profile between RA and PsA synovium and synovial fluid, and reports potential clinically useful lipid markers for the differential diagnosis of these diseases.

Figure 1. Increased levels of PE 34:1 and PE 36:1 in the PsA synovium and synovial fluid compared to RA. A) Images show samples from two representative RA and PsA biopsies stained with hematoxylin and eosin. B) MALDI-MSI images showing the differences in the abundance and spatial distribution of PE 34:1 and PE 36:1 in PsA synovium compared to RA samples. The colour scale at the bottom left indicates the relative abundance. Pink or white denote higher abundances, while blue or black denote lower abundances. C) SF levels of PE 34:1 and PE 36:1 are increased in PsA patients compared to RA. Y-axis represents concentrations in pg/µl. **p-value < 0.01. PE, phosphatidylethanolamine; RA, rheumatoid arthritis; PsA, psoriatic arthritis; SF, synovial fluid.


Disclosures: B. Rocha, None; B. Cillero-Pastor, None; A. Illiano, None; V. Calamia, None; G. Pinto, None; A. Amoresano, None; C. Ruiz-Romero, None; J. Cañete, Abbvie, 6, Pfizer, 6, Janssen, 6; R. Heeren, None; F. Blanco-García, None.

To cite this abstract in AMA style:

Rocha B, Cillero-Pastor B, Illiano A, Calamia V, Pinto G, Amoresano A, Ruiz-Romero C, Cañete J, Heeren R, Blanco-García F. Distinct Lipidomic Signatures in Synovium and Synovial Fluid of Patients with Rheumatoid Arthritis versus Psoriatic Arthritis [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/distinct-lipidomic-signatures-in-synovium-and-synovial-fluid-of-patients-with-rheumatoid-arthritis-versus-psoriatic-arthritis/. Accessed January 27, 2023.
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/distinct-lipidomic-signatures-in-synovium-and-synovial-fluid-of-patients-with-rheumatoid-arthritis-versus-psoriatic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences